v3.26.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 157,399 $ 282,029
Restricted cash 14,174 28,842
Inventories 707,956 606,302
Prepaid expenses and other current assets 196,769 98,395
Total current assets 2,095,018 1,911,181
Property, plant and equipment, net 572,634 442,950
Goodwill 772,473 595,470
Intangible assets, net 1,551,255 563,498
Financing lease right-of-use assets 63,255 53,328
Other assets 122,807 57,805
Total assets 5,267,221 3,678,280
Current liabilities:    
Current portion of liabilities for legal matters 27,534 43,256
Revolving credit facility 180,000 0
Current portion of long-term debt, net 23,933 6,761
Current portion of financing lease liabilities 3,811 3,442
Contingent consideration - related party - short term 59,000 0
Total current liabilities 1,119,837 881,633
Long-term debt, net 2,915,501 2,565,115
Financing lease liabilities 65,588 54,927
Liabilities for legal matters - long term 71,663 71,819
Contingent consideration - related party - long term 324,000 0
Total long-term liabilities 3,506,674 2,790,684
Commitments and contingencies (Notes 4, 18 and 20)
Redeemable non-controlling interests 109,453 77,292
Stockholders’ Equity (Deficiency)    
Preferred stock, $0.01 par value, 2,000 shares authorized at both September 30, 2026 and December 31, 2025; none issued at both September 30, 2026 and December 31, 2025 0 0
Additional paid-in capital 1,047,639 571,794
Stockholders’ accumulated deficit (436,782) (535,005)
Accumulated other comprehensive loss (83,084) (110,729)
Total Amneal Pharmaceuticals, Inc. stockholders’ equity (deficiency) 531,257 (70,794)
Non-controlling interests 0 (535)
Total stockholders’ equity (deficiency) 531,257 (71,329)
Total liabilities and stockholders’ equity (deficiency) 5,267,221 3,678,280
Common Class A    
Stockholders’ Equity (Deficiency)    
Common stock 3,484 3,146
Common Class B    
Stockholders’ Equity (Deficiency)    
Common stock 0 0
Nonrelated Party    
Current assets:    
Receivables 1,016,844 895,143
Operating lease right-of-use assets 69,760 38,832
Current liabilities:    
Accounts payable and accrued expenses 788,831 761,316
Current portion of operating lease liabilities 14,417 8,668
Operating lease liabilities 59,612 33,233
Related party payables - long term 37,797 32,263
Related Party    
Current assets:    
Receivables 1,876 470
Operating lease right-of-use assets 20,019 15,216
Current liabilities:    
Accounts payable and accrued expenses 18,913 55,485
Current portion of operating lease liabilities 3,398 2,705
Operating lease liabilities 16,635 14,195
Related party payables - long term $ 15,878 $ 19,132